Does pre-emptive kidney transplantation with a deceased donor improve outcomes? Results from a French transplant network

Transplant International

Volumn 24, Issue 3, 2011, Pages 266-275

  Kessler, Michèle ^a   Ladriere, Marc ^a   Giral, Magali ^b   Soulillou, Jean Paul ^b   Legendre, Christophe ^c   Martinez, Franck ^c   Rostaing, Lionel ^d   Alla, François ^a,e  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Institut de Transplantation et de Recherche en Transplantation (ITERT)   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e INSERM   (France)

Author keywords

kidney clinical; outcome

Indexed keywords

ADULT; AGE; AGE DISTRIBUTION; ARTICLE; BLOOD GROUP; CADAVER DONOR; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DIALYSIS; DONOR AGE; FEMALE; FRANCE; GRAFT SURVIVAL; HUMAN; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX RATIO; SURVIVAL RATE;

EID: 79551571428     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01195.x     Document Type: Article

References (25)

1. Rabbat CG, Thorpe KE, Russel JD, Churchill DN,. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol 2000; 11: 917.
2. Schnuelle P, Lorenz D, Trede M, Van der Woude PJ,. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 1998; 9: 2135.
3. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
4. Oniscu GC, Brown H, Forsythe JLR,. Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol 2005; 16: 1859.
5. Kasiske BL, Snyder BL, Matas AJ, Ellison MD, Gill JS, Kausz AT,. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol 2002; 13: 1358.
6. Roake JA, Cahill AP, Gray CM, Gray WR, Morris PJ,. Preemptive cadaveric renal transplantation-clinical outcome. Transplantation 1996; 10: 1411.
7. Meier-Kriesche HU, Port FK, Ojo AO, et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58: 1311.
8. Katz SM, Kerman RH, Golden D, et al. Preemptive transplantation: an analysis of benefits and hazards in 85 cases. Transplantation 1991; 51: 351.
9. Papalois VE, Moss A, Gillingham KJ, Sutherland DER, Matas AJ, Humar A,. Pre-emptive transplants for patients with renal failure. An argument against waiting until dialysis. Transplantation 2000; 70: 625.
10. Berthoux FC, Jones EH, Mehls O, Valderrabano F,. Transplantation report. 2: Pre-emptive renal transplantation in adults aged over 15 years. The EDTA-ERA Registry. European Dialysis and Transplant Association. Nephrol Dial Transplant 1996; 11 (Suppl. 1): 41.
11. Chalem Y, Ryckelynck JP, Tuppin P, Verger C, Chauvé S, Glotz D,. Access to and outcome of renal transplantation according to treatment modality of end-stage renal disease in France. Kidney Int 2005; 67: 2448.
12. Dantal J, Hourmant M, Cantarovich D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351: 623.
13. Abecassis M, Bartlett ST, Collins AJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI) conference. Clin J Am Soc Nephrol 2008; 3: 471.
14. Asderakis A, Augustine T, Dyer P, et al. Pre-emptive kidney transplantation: the attractive alternative. Nephrol Dial Transplant 1998; 13: 1799.
15. Rapport d'activité 2006 de l'agence de la biomédecine. Available from:. http://www.agence-biomedecine.fr/fr/rapport-2006/organes/6- greffe-renale/6-1/tr6.htm. 16-7-2008. Internet Communication.
16. Ashby VB, Kalbfleisch JD, Wolfe RA, Lin MJ, Port FK, Leichtman AB,. Geographic variability in access to primary kidney transplantation in the United State, 1996-2005. Am J Transplant 2007; 7 (Suppl. 1): 1412.
17. Becker BN, Rush SH, Dykstra DM, Becker YT, Port FK,. Preemptive transplantation for patients with diabetes-related kidney disease. Arch Intern Med 2006; 166: 44.
18. Gill JS, Tonelli M, Johnson N, Pereira BJG,. Why do preemptive kidney transplant recipients have an allograft survival advantage? Transplantation 2004; 78: 873.
19. Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, et al. Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant 2005; 20: 167.
20. Innocenti GR, Wadei HM, Prieto M, et al. Preemptive living donor kidney transplantation: do the benefits extend to all recipients? Transplantation 2007; 83: 144.
21. Mange KC, Joffe MM, Feldman HI,. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 2001; 344: 726.
22. Pérez-Flores I, Sanchez-Fructuoso A, Calvo N, et al. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list. Transplant Proc 2007; 39: 2123.
23. Cosio FG, Alamir A, Yim S, et al. Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 1998; 53: 767.
24. Meier-Kriesche HU, Kaplan B,. Waiting time on dialysis as the strongest modifiable risk factor for renal transplantation outcomes. Transplantation 2002; 74: 1377.
25. Witczak BJ, Leivestad T, Line PD, et al. Experience from an active preemptive kidney transplantation program-809 cases revisited. Transplantation 2009; 88: 672.